Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Alisertib for Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Amir Fathi, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01779843
First received: January 25, 2013
Last updated: March 14, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)